497 genotypes with 525 annotations displayed
of selected term and subterms
|
Searched Term: decreased inflammatory response
|
Abcc1tm1Bor/Abcc1tm1Bor
(involves: 129P2/OlaHsd * FVB)
|
decreased inflammatory response
|
J:44110
|
Acot11tm1Deco/Acot11tm1Deco
(involves: 129S6/SvEvTac * C57BL/6)
|
decreased inflammatory response
|
J:182660
|
Adam17tm1Bbl/Adam17tm1Bbl Lyz2tm1(cre)Ifo/0
(involves: 129P2/OlaHsd)
|
decreased susceptibility to endotoxin shock
|
J:139846
|
Adam17tm1Bbl/Adam17tm1Bbl Tg(Mx1-cre)1Cgn/0
(involves: 129P2/OlaHsd * C57BL/6 * CBA)
|
decreased susceptibility to endotoxin shock
|
J:139846
|
Adora3tm1Jbsn/Adora3tm1Jbsn
(involves: 129P2/OlaHsd * C57BL/6 * DBA/2)
|
decreased acute inflammation
|
J:120442
|
Ahrtm1Bra/Ahrtm1Bra
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
decreased susceptibility to type IV hypersensitivity reaction
|
J:148870
|
Aimp1Gt(OST58507)Lex/Aimp1Gt(OST58507)Lex
(involves: 129S5/SvEvBrd * C57BL/6)
|
decreased inflammatory response
|
J:95974
|
Akip1em1Cya/Akip1em1Cya
(C57BL/6N-Akip1em1Cya)
|
decreased susceptibility to endotoxin shock
|
J:326919
|
Alox5tm1Bhk/Alox5tm1Bhk
(either: (involves: 129P2/OlaHsd * C57BL/6) or (involves: 129P2/OlaHsd * C57BL/6 * DBA/2))
|
decreased acute inflammation
|
J:68714
|
decreased susceptibility to type I hypersensitivity reaction
|
J:68714
|
Alox5tm1Fun/Alox5tm1Fun
(involves: 129S2/SvPas * C57BL/6)
|
decreased inflammatory response
|
J:21372,
J:75371
|
Alox5aptm1Bhk/Alox5aptm1Bhk
(involves: 129P2/OlaHsd * C57BL/6 * DBA/2)
|
decreased susceptibility to type I hypersensitivity reaction
|
J:39229
|
Alox5aptm1Bhk/Alox5aptm1Bhk
(involves: 129P2/OlaHsd * 129S/SvEv)
|
decreased acute inflammation
|
J:39229
|
Alox5aptm1Jdm/Alox5aptm1Jdm
(DBA/1LacJ-Alox5aptm1Jdm)
|
decreased inflammatory response
|
J:100736
|
Anxa5tm1Epo/Anxa5tm1Epo
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased susceptibility to type IV hypersensitivity reaction
|
J:117249
|
Aoc3tm1Salm/Aoc3tm1Salm
(involves: 129S6/SvEvTac * 129S7/SvEvBrd)
|
decreased inflammatory response
|
J:95656
|
Apba3tm1.1Ski/Apba3tm1.1Ski Lyz2tm1(cre)Ifo/Lyz2+
(B6.129-Apba3tm1.1Ski Lyz2tm1(cre)Ifo)
|
decreased susceptibility to endotoxin shock
|
J:176742
|
Apba3tm1.2Ski/Apba3tm1.2Ski
(B6.129-Apba3tm1.2Ski)
|
decreased susceptibility to endotoxin shock
|
J:176742
|
Apcstm1Smae/Apcstm1Smae
(involves: 129S/SvEv * C57BL/6)
|
decreased susceptibility to endotoxin shock
|
J:71194
|
Apoetm1Unc/Apoetm1Unc
(B6.129P2-Apoetm1Unc/J)
|
decreased susceptibility to type IV hypersensitivity reaction
|
J:61564
|
Apoetm1Unc/Apoetm1Unc Ncf1tm1Shl/Ncf1tm1Shl
(involves: 129P2/OlaHsd * 129S2/SvPas)
|
decreased acute inflammation
|
J:123854
|
Apoetm1Unc/Apoetm1Unc Nck1tm1Paw/Nck1tm1Paw Nck2tm3Paw/Nck2tm3Paw Tg(Cdh5-cre/ERT2)1Rha/0
(involves: 129P2/OlaHsd * 129S1/Sv * 129X1/SvJ * C57BL/6)
|
decreased inflammatory response
|
J:326659
|
Apol6em1Hsul/Apol6em1Hsul
(Not Specified)
|
decreased inflammatory response
|
J:344362
|
Arel1em1Bbc/Arel1+
(C57BL/6J-Arel1em1Bbc)
|
decreased acute inflammation
|
J:280563
|
Arel1em1Bbc/Arel1em1Bbc
(C57BL/6J-Arel1em1Bbc)
|
decreased acute inflammation
|
J:280563
|
Atp5if1em1Jpy/Atp5if1em1Jpy
(C57BL/6J-Atp5if1em1Jpy)
|
decreased susceptibility to colitis induced morbidity/mortality
|
J:312819
|
AW112010em2Flv/AW112010em2Flv
(involves: C57BL/6N)
|
decreased susceptibility to induced colitis
|
J:267975
|
B4galt1tm1Yiw/B4galt1tm1Yiw
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)
|
decreased acute inflammation
|
J:106669
|
decreased susceptibility to type IV hypersensitivity reaction
|
J:106669
|
B4gat1tm1Mifu/B4gat1tm1Mifu Gcnt1tm1Jxm/Gcnt1tm1Jxm
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
decreased susceptibility to type IV hypersensitivity reaction
|
J:120722
|
Bbs12tm1.1Vmar/Bbs12tm1.1Vmar
(involves: 129S6/SvEvTac * C57BL/6)
|
decreased inflammatory response
|
J:189019
|
Bcl2a1atm1Prys/Bcl2a1atm1Prys
(involves: 129/Sv * C57BL/6J * SJL)
|
decreased inflammatory response
|
J:74478
|
Bdkrb1tm1Bdr/Bdkrb1tm1Bdr
(involves: 129P2/OlaHsd)
|
decreased susceptibility to endotoxin shock
|
J:135789
|
Bdkrb1tm2Bdr/Bdkrb1tm2Bdr Bdkrb2tm1Jfh/Bdkrb2tm1Jfh
(involves: 129S7/SvEvBrd * C57BL/6)
|
decreased susceptibility to endotoxin shock
|
J:135789
|
Bidtm1Sjk/Bidtm1Sjk
(involves: 129X1/SvJ * C57BL/6)
|
decreased susceptibility to endotoxin shock
|
J:117693
|
Birc3tm1Rgk/Birc3tm1Rgk
(B6.129X1-Birc3tm1Rgk)
|
decreased susceptibility to endotoxin shock
|
J:144012
|
Btkxid/Btkxid
(CBA/CaHN-Btkxid/J)
|
decreased acute inflammation
|
J:92639
|
C9em1Sjlg/C9em1Sjlg
(C57BL/6-C9em1Sjlg)
|
decreased susceptibility to endotoxin shock
|
J:301607
|
Card14em3Tshu/Card14+ Il17atm1Cdon/Il17atm1Cdon
(involves: C57BL/6)
|
decreased inflammatory response
|
J:289239
|
Casp1tm1Flv/Casp1tm1Flv Casp4del/Casp4del
(involves: 129S2/SvPas * C57BL/6)
|
decreased susceptibility to endotoxin shock
|
J:43088
|
Casp1tm1Flv/Casp1tm1Flv Casp4del/Casp4del Il1r1tm1Imx/Il1r1tm1Imx
(involves: 129S2/SvPas * 129S7/SvEvBrd * C57BL/6)
|
decreased susceptibility to endotoxin shock
|
J:43088
|
Casp1tm1Sesh/Casp1tm1Sesh Casp4del/Casp4del
(involves: 129S2/SvPas * C57BL/6)
|
decreased susceptibility to endotoxin shock
|
J:22964,
J:40691
|
Casp1tm1Sesh/Casp1tm1Sesh Casp4del/Casp4del
(B10.Cg-Casp1tm1Sesh Casp4del H2r H2-T18b)
|
decreased inflammatory response
|
J:63488
|
Casp1tm1Sesh/Casp1tm1Sesh Casp4del/Casp4del
(B6.129S2(NOD)-Casp1tm1Sesh Casp4del)
|
decreased susceptibility to endotoxin shock
|
J:193522
|
Casp1tm1Sesh/Casp1tm1Sesh Casp4del/Casp4del Tg(Casp4)#Gne/0
(involves: 129S2/SvPas * C57BL/6 * NOD/ShiLtJ)
|
decreased susceptibility to endotoxin shock
|
J:193522
|
Casp3tm1Mak/Casp3tm1Mak
(B6.129P2-Casp3tm1Mak)
|
decreased inflammatory response
|
J:97650,
J:179279
|
Casp4tm1.1Vmd/Casp4tm1.1Vmd
(involves: C57BL/6)
|
decreased susceptibility to endotoxin shock
|
J:193522
|
Casp4tm1Yuan/Casp4tm1Yuan
(involves: 129S4/SvJae * C57BL/6J * DBA/2)
|
decreased susceptibility to endotoxin shock
|
J:46167
|
Cav1tm1Mls/Cav1tm1Mls
(involves: 129/Sv * C57BL/6 * SJL)
|
decreased susceptibility to endotoxin shock
|
J:139304
|
Ccdc92tm1a(KOMP)Mbp/Ccdc92tm1a(KOMP)Mbp
(C57BL/6N-Ccdc92tm1a(KOMP)Mbp)
|
decreased inflammatory response
|
J:332421
|
Cckbrtm1Tom/Cckbrtm1Tom
(involves: 129S4/SvJae * C57BL/6J)
|
decreased susceptibility to endotoxin shock
|
J:143853
|
Ccl2tm1Rol/Ccl2tm1Rol
(involves: 129S4/SvJae * 129X1/SvJ * C57BL/6)
|
decreased susceptibility to type IV hypersensitivity reaction
|
J:45920
|
Ccl2tm1Rol/Ccl2tm1Rol
(involves: 129S4/SvJae * C57BL/6)
|
decreased susceptibility to induced colitis
|
J:116878
|
Ccl2tm1Rol/Ccl2tm1Rol
(involves: 129S4/SvJae)
|
decreased inflammatory response
|
J:155025
|
Ccl3tm1Unc/Ccl3tm1Unc
(B6.129P2-Ccl3tm1Unc/J)
|
decreased susceptibility to type III hypersensitivity reaction
|
J:94599
|
Ccl5tm1Hso/Ccl5tm1Hso
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased susceptibility to type IV hypersensitivity reaction
|
J:75842
|
Ccl17tm1.1Ifo/Ccl17tm1.1Ifo
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased susceptibility to type IV hypersensitivity reaction
|
J:159098
|
Ccr1tm1Gao/Ccr1tm1Gao
(involves: C57BL/6)
|
decreased susceptibility to type III hypersensitivity reaction
|
J:94599
|
Ccr2tm1Ifc/Ccr2tm1Ifc
(B6.129S4-Ccr2tm1Ifc/J)
|
decreased acute inflammation
|
J:106738
|
Ccr2tm1Ifc/Ccr2tm1Ifc
(involves: 129S4/SvJae * C57BL/6)
|
decreased inflammatory response
|
J:44345
|
decreased susceptibility to type I hypersensitivity reaction
|
J:118971
|
Ccr2tm1Ifc/Ccr2tm1Ifc
(B6.129S4-Ccr2tm1Ifc)
|
decreased susceptibility to induced colitis
|
J:161138
|
Ccr2tm1Mae/Ccr2tm1Mae
(involves: 129P2/OlaHsd * C57BL/6J)
|
decreased inflammatory response
|
J:110814
|
Ccr4tm1Pwr/Ccr4tm1Pwr
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased susceptibility to endotoxin shock
|
J:70088
|
Ccr5tm1Brv/Ccr5tm1Brv
(either: (involves: 129S1/Sv * ICR) or (involves: 129S1/Sv * 129X1/SvJ * ICR))
|
decreased susceptibility to endotoxin shock
|
J:46941
|
Ccr5tm1Kuz/Ccr5tm1Kuz
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased susceptibility to induced colitis
|
J:110814
|
Ccr5tm1Kuz/Ccr5tm1Kuz
(involves: 129P2/OlaHsd)
|
decreased inflammatory response
|
J:227458
|
Ccr6tm1.1Jmf/Ccr6tm1.1Jmf
(B6.129-Ccr6tm1.1Jmf)
|
decreased inflammatory response
|
J:152716
|
Ccr6tm1Gma/Ccr6tm1Gma
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
decreased inflammatory response
|
J:68191
|
Ccr6tm1Lira/Ccr6tm1Lira
(involves: 129 * C57BL/6)
|
decreased inflammatory response
|
J:124358
|
Ccr6tm1Lira/Ccr6tm1Lira
(B6.129-Ccr6tm1Lira)
|
decreased susceptibility to type I hypersensitivity reaction
|
J:71096
|
Ccr7tm1Rfor/Ccr7tm1Rfor
(involves: 129P2/OlaHsd * BALB/c)
|
decreased susceptibility to type IV hypersensitivity reaction
|
J:57976
|
Ccrl2tm1Lex/Ccrl2tm1Lex
(involves: 129S/SvEvBrd * C57BL/6)
|
decreased susceptibility to type I hypersensitivity reaction
|
J:140110
|
Cd1d1tm1Luc/Cd1d1tm1Luc
(involves: 129S6/SvEvTac * C57BL/6)
|
decreased acute inflammation
|
J:93915
|
Cd14hdl/Cd14hdl
(C57BL/6-Cd14hdl)
|
decreased susceptibility to endotoxin shock
|
J:98908
|
Cd14tm1Frm/Cd14tm1Frm
(involves: 129S4/SvJae)
|
decreased susceptibility to endotoxin shock
|
J:98908
|
Cd14tm1Smg/Cd14tm1Smg
(involves: 129S1/Sv * C57BL/6)
|
decreased susceptibility to endotoxin shock
|
J:32729
|
Cd28tm1Pjl/Cd28tm1Pjl
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased susceptibility to type IV hypersensitivity reaction
|
J:83722
|
Cd28tm1Pjl/Cd28tm1Pjl Tnfrsf9tm1Byk/Tnfrsf9tm1Byk
(either: B6.Cg-Cd28tm1Pjl Tnfrsf9tm1Byk or C.Cg-Cd28tm1Pjl Tnfrsf9tm1Byk)
|
decreased susceptibility to type IV hypersensitivity reaction
|
J:83722
|
Cd33tm1Avrk/Cd33tm1Avrk
(involves: 129X1/SvJ * C57BL/6)
|
decreased inflammatory response
|
J:83728
|
Cd40tm1Kik/Cd40tm1Kik
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased susceptibility to type II hypersensitivity reaction
|
J:61673
|
Cd44tm1Mak/Cd44tm1Mak
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased acute inflammation
|
J:114341
|
Cd44tm2Kmz/Cd44tm2Kmz
(involves: BALB/c * DBA/1)
|
decreased susceptibility to type IV hypersensitivity reaction
|
J:114317
|
Cd44tm2Kmz/Cd44tm2Kmz Selltm2Hyn/Selltm2Hyn
(involves: 129S2/SvPas * BALB/c * DBA/1)
|
decreased susceptibility to type IV hypersensitivity reaction
|
J:114317
|
Cd74tm1Liz/Cd74tm1Liz
(B6.129S-Cd74tm1Liz)
|
decreased susceptibility to type IV hypersensitivity reaction
|
J:125654
|
Cd81tm1Lvy/Cd81tm1Lvy
(CByJ.129-Cd81tm1Lvy)
|
decreased susceptibility to type I hypersensitivity reaction
|
J:46171
|
Cd83lcd4/Cd83lcd4
(involves: C57BL/6J)
|
decreased susceptibility to type IV hypersensitivity reaction
|
J:92721
|
Cd83tm1Tft/Cd83tm1Tft
(involves: 129S4/SvJae * C57BL/6)
|
decreased susceptibility to type IV hypersensitivity reaction
|
J:75700
|
Cd99l2tm1.1Dvst/Cd99l2tm1.1Dvst Tg(Tek-cre)1Ywa/0
(involves: 129S6/SvEvTac * BALB/c * C57BL/6)
|
decreased susceptibility to type IV hypersensitivity reaction
|
J:193021
|
Cd207tm1(Hbegf/EGFP)Bjec/Cd207+
(involves: C57BL/6 * SJL)
|
decreased susceptibility to type IV hypersensitivity reaction
|
J:137517
|
Cd209btm1Anjm/Cd209btm1Anjm
(B6.129P2-Cd209btm1Anjm)
|
decreased susceptibility to endotoxin shock
|
J:159646
|
decreased susceptibility to induced colitis
|
J:159646
|
Cd226tm1.1Cln/Cd226tm1.1Cln
(B6.129P2-Cd226tm1.1Cln)
|
decreased inflammatory response
|
J:209990
|
Cebpbtm1Aki/Cebpbtm1Aki
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased susceptibility to endotoxin shock
|
J:153025
|
Cebpbtm1Vpo/Cebpbtm1Vpo
(involves: 129S/SvEv * MF1)
|
decreased susceptibility to type IV hypersensitivity reaction
|
J:25215
|
Cebpdtm1Pfj/Cebpdtm1Pfj
(involves: 129S1/Sv * C57BL/6)
|
decreased inflammatory response
|
J:192313
|
Cers6tm1.1Arte/Cers6tm1.1Arte
(involves: BALB/cJ * C57BL/6N)
|
decreased inflammatory response
|
J:215519
|
Cia6DBA/1J/Cia6DBA/1J
(involves: B10.Q * DBA/1)
|
decreased inflammatory response
|
J:57012
|
Cia23C57BL/10SnSg/Cia23NOD/ShiLtJ Cia9C57BL/10SnSg/Cia9C57BL/10SnSg
(involves: B10.D1-H2q/SgJ * NOD.C3-H2q/Rhd)
|
decreased inflammatory response
|
J:69981
|
Clec4dtm1.1Shoy/Clec4dtm1.1Shoy
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased susceptibility to type IV hypersensitivity reaction
|
J:203159
|
Clec4etm1Tks/Clec4etm1Tks
(involves: 129S1/Sv * 129X1/SvJ)
|
decreased susceptibility to type IV hypersensitivity reaction
|
J:203159
|
Clic4tm1.1Aidi/Clic4tm1.1Aidi
(involves: C57BL/6 * C57BL/6J)
|
decreased susceptibility to endotoxin shock
|
J:175404
|
Cmtm4tm1d(EUCOMM)Wtsi/Cmtm4tm1d(EUCOMM)Wtsi
(involves: C57BL/6J * C57BL/6N)
|
decreased inflammatory response
|
J:333836
|
Cpa3tm3(icre)Hrr/Cpa3+
(involves: 129P2/OlaHsd * BALB/c * C57BL/6)
|
decreased susceptibility to type I hypersensitivity reaction
|
J:178942
|
Creb3l3tm1.1Sad/Creb3l3tm1.1Sad
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * FVB/N)
|
decreased acute inflammation
|
J:140018
|
Crhtm1Maj/Crhtm1Maj
(involves: 129S2/SvPas * C57BL/6)
|
decreased inflammatory response
|
J:90690,
J:72196
|
Csf2tm1Dran/Csf2tm1Dran Il3tm1Glli/Il3tm1Glli
(B6.129S2-Csf2tm1Dran Il3tm1Glli)
|
decreased susceptibility to type IV hypersensitivity reaction
|
J:67404
|
Csf2tm1Dran/Csf2tm1Dran Il3tm1Glli/Il3tm1Glli
(C.129S2-Csf2tm1Dran Il3tm1Glli)
|
decreased susceptibility to type IV hypersensitivity reaction
|
J:67404
|
Csf2rbtm1Clsc/Csf2rbtm1Clsc Csf2rb2tm1Cgb/Csf2rb2tm1Cgb
(C.129S1-Csf2rb2tm1Cgb Csf2rbtm1Clsc)
|
decreased susceptibility to type I hypersensitivity reaction
|
J:130939
|
Ct55em1Xdzg/Ct55em1Xdzg
(involves: C57BL/6)
|
decreased susceptibility to induced colitis
|
J:280149
|
Ctsgtm1.1Roes/Ctsgtm1.1Roes Elanetm1(cre)Roes/Elanetm1(cre)Roes
(involves: 129P2/OlaHsd)
|
decreased susceptibility to endotoxin shock
|
J:77597
|
Cx3cl1tm1.1Yono/Cx3cl1tm1.1Yono
(involves: C57BL/6J)
|
decreased inflammatory response
|
J:271242
|
Cx3cr1tm1Litt/Cx3cr1tm1Litt
(involves: 129P2/OlaHsd)
|
decreased inflammatory response
|
J:271242
|
Cxcl5tm1Gscw/Cxcl5tm1Gscw
(involves: 129)
|
decreased susceptibility to endotoxin shock
|
J:162629
|
Cxcl9tm1Jmf/Cxcl9tm1Jmf
(B6.129S4-Cxcl9tm1Jmf)
|
decreased inflammatory response
|
J:120743
|
Cxcl10tm1Adl/Cxcl10tm1Adl
(involves: 129S4/SvJae * 129X1/SvJ)
|
decreased susceptibility to type IV hypersensitivity reaction
|
J:75584
|
Cybatm1Dgh/Cybatm1Dgh
(B6.Cg-Cybatm1Dgh)
|
decreased inflammatory response
|
J:231269
|
Cysltr1tm1Ykn/Cysltr1tm1Ykn
(involves: C57BL/6)
|
decreased susceptibility to type I hypersensitivity reaction
|
J:77087
|
Cysltr2tm1Ykn/Cysltr2tm1Ykn
(C57BL/6-Cysltr2tm1Ykn)
|
decreased susceptibility to type I hypersensitivity reaction
|
J:94488
|
Cyth2tm1d(EUCOMM)Wtsi/Cyth2tm1d(EUCOMM)Wtsi
(involves: C57BL/6N)
|
decreased susceptibility to type I hypersensitivity reaction
|
J:307633
|
Ddit3tm1Dron/Ddit3tm1Dron Tg(Col2a1-rtTA,tetO-COMP*)2Jath/0
(involves: 129X1/SvJ * 129S1/Sv * C57BL/6)
|
decreased inflammatory response
|
J:233238
|
Del(13Naip1-Naip5)1Vnce/Del(13Naip1-Naip5)1Vnce
(involves: C57BL/6)
|
decreased inflammatory response
|
J:294930
|
Del(13Naip1-Naip5)1Vnce/Del(13Naip1-Naip5)1Vnce Nlrc4em2Vnce/Nlrc4em2Vnce
(involves: C57BL/6)
|
decreased inflammatory response
|
J:294930
|
Del(13Naip1-Naip5)1Vnce/Del(13Naip1-Naip5)1Vnce Nlrp3tm1Vmd/Nlrp3tm1Vmd
(involves: C57BL/6J * C57BL/6N)
|
decreased inflammatory response
|
J:294930
|
Ebi3tm1Rsb/Ebi3tm1Rsb
(involves: 129X1/SvJ * C57BL/6)
|
decreased susceptibility to induced colitis
|
J:81014
|
Ecm1tm1Bsun/Ecm1tm1Bsun
(involves: 129 * C57BL/6)
|
decreased susceptibility to type I hypersensitivity reaction
|
J:168252
|
Ednrbtm1Ywa/Ednrb+
(involves: 129S/SvEvBrd)
|
decreased acute inflammation
|
J:103977
|
Ednrbtm1Ywa/Ednrbtm1Ywa
(involves: 129S5/SvEvBrd)
|
decreased acute inflammation
|
J:103977
|
Eef1a2wst/Eef1a2wst
(B6C3Fe a/a-Eef1a2wst/J)
|
decreased susceptibility to type IV hypersensitivity reaction
|
J:6766
|
Egr1tm1Jmi/Egr1tm1Jmi
(involves: 129 * C57BL/6)
|
decreased inflammatory response
|
J:152898
|
Elavl1tm1Lix/Elavl1tm1Lix Tg(Scgb1a1-rtTA)2Jaw/0 Tg(tetO-cre)1Jaw/0
(involves: 129 * C57BL/6)
|
decreased inflammatory response
|
J:204952
|
Enpp2tm1Lex/Enpp2+
(involves: 129S/SvEvBrd * C57BL/6J)
|
decreased susceptibility to endotoxin shock
|
J:103485
|
Ephb6tm1Jwu/Ephb6tm1Jwu
(involves: 129)
|
decreased susceptibility to type IV hypersensitivity reaction
|
J:94701
|
F2tm2Jld/F2+
(B6.129P2-F2tm2Jld)
|
decreased susceptibility to endotoxin shock
|
J:174629
|
F2rtm1Pago/F2rtm1Pago
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased inflammatory response
|
J:124648
|
decreased susceptibility to induced colitis
|
J:94420
|
F2rtm1Pago/F2rtm1Pago
(involves: 129P2/OlaHsd)
|
decreased susceptibility to endotoxin shock
|
J:133917
|
F2rl1tm1Bpd/F2rl1tm1Bpd
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased inflammatory response
|
J:124648
|
F2rl1tm1Bpd/F2rl1tm1Bpd
(B6.129P2-F2rl1tm1Bpd)
|
decreased susceptibility to endotoxin shock
|
J:88245
|
F2rl1tm1Jkaw/F2rl1tm1Jkaw
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased susceptibility to type IV hypersensitivity reaction
|
J:106127
|
F2rl1tm1Mslb/F2rl1tm1Mslb
(involves: 129X1/SvJ * C57BL/6)
|
decreased inflammatory response
|
J:79757
|
F3tm1.1Dwr/F3tm1.1Dwr
(involves: 129S1/Sv * 129X1/SvJ * MF1 * Swiss)
|
decreased susceptibility to endotoxin shock
|
J:91165
|
F3tm1Dco/F3tm1Dco Tg(F3)1Nmk/0
(B6.Cg-F3tm1Dco Tg(F3)1Nmk)
|
decreased susceptibility to endotoxin shock
|
J:88245
|
Faslpr/Faslpr Fcer1gtm1Tks/Fcer1gtm1Tks
(MRL.Cg-Fcer1gtm1Tks Faslpr)
|
decreased susceptibility to type III hypersensitivity reaction
|
J:106188
|
Fcer1atm1Knt/Fcer1atm1Knt
(either: (involves: 129 * C57BL/6) or (involves: 129 * C57BL/6 * DBA/2))
|
decreased susceptibility to type I hypersensitivity reaction
|
J:113572,
J:39250
|
Fcer1gtm1Rav/Fcer1gtm1Rav
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased susceptibility to type I hypersensitivity reaction
|
J:78659,
J:39248
|
Fcer1gtm1Tks/Fcer1gtm1Tks
(involves: C57BL/6)
|
decreased inflammatory response
|
J:50023
|
decreased susceptibility to type IV hypersensitivity reaction
|
J:112160
|
Fcgr1tm1Hoga/Fcgr1tm1Hoga
(involves: 129S1/Sv * 129X1/SvJ)
|
decreased inflammatory response
|
J:86281
|
Fcgr3tm1Jsv/Fcgr3tm1Jsv
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased susceptibility to type II hypersensitivity reaction
|
J:35057
|
Fcgr3tm1Ttk/Fcgr3tm1Ttk
(involves: 129X1/SvJ)
|
decreased susceptibility to type I hypersensitivity reaction
|
J:107371
|
Ffar2tm2Lex/Ffar2tm2Lex
(involves: 129S7/SvEvBrd * C57BL/6)
|
decreased susceptibility to induced colitis
|
J:157383
|
Flgtm1Amag/Flgtm1Amag Tg(CD207-Dta)312Dhka/0
(involves: 129S6/SvEvTac * BALB/c * C57BL/6NTac * FVB)
|
decreased inflammatory response
|
J:229771
|
Foxn1nu/Foxn1nu Tgfb1tm1Doe/Tgfb1tm1Doe
(involves: 129S2/SvPas * BALB/c * CF-1)
|
decreased inflammatory response
|
J:99033
|
Fpr2tm1.1Jimw/Fpr2tm1.1Jimw Lyz2tm1(cre)Ifo/Lyz2+
(involves: 129P2/OlaHsd * 129X1/SvJ)
|
decreased susceptibility to induced colitis
|
J:197568
|
Fpr2tm1.2Jimw/Fpr2tm1.2Jimw
(B6.129X1-Fpr2tm1.2Jimw)
|
decreased inflammatory response
|
J:160074
|
Fpr2tm1.2Jimw/Fpr2tm1.2Jimw
(involves: 129X1/SvJ)
|
decreased acute inflammation
|
J:197568
|
Fut4tm1Jbl/Fut4tm1Jbl Fut7tm1Jbl/Fut7tm1Jbl
(B6.129S2-Fut7tm1Jbl Fut4tm1Jbl)
|
decreased susceptibility to type IV hypersensitivity reaction
|
J:79388
|
Fut7tm1Jbl/Fut7tm1Jbl
(B6.129S2-Fut7tm1Jbl)
|
decreased susceptibility to type IV hypersensitivity reaction
|
J:79388,
J:74776
|
Gab2tm1Hhg/Gab2tm1Hhg
(involves: 129S4/SvJae)
|
decreased susceptibility to type I hypersensitivity reaction
|
J:70424
|
Gab2tm3.1Thir/Gab2tm3.1Thir
(involves: 129T/SvJcl * C57BL/6Jcl)
|
decreased susceptibility to type I hypersensitivity reaction
|
J:178045
|
Gab2tm4.1Thir/Gab2tm4.1Thir
(involves: 129T/SvJcl * C57BL/6Jcl)
|
decreased susceptibility to type I hypersensitivity reaction
|
J:178045
|
Gcatm1Roes/Gcatm1Roes
(involves: 129P2/OlaHsd * 129S2/SvPas)
|
decreased susceptibility to endotoxin shock
|
J:81436
|
Gfaptm1Pkny/Gfaptm1Pkny Vimtm1Cba/Vimtm1Cba
(involves: 129P2/OlaHsd * 129S2/SvPas * C57BL/6)
|
decreased inflammatory response
|
J:123278
|
Ggt5tm1Mwl/Ggt5tm1Mwl
(involves: 129S7/SvEvBrd * C57BL/6J)
|
decreased acute inflammation
|
J:77691
|
Gm16685em1Osb/Gm16685em1Osb
(C57BL/6N-Gm16685em1Osb)
|
decreased susceptibility to colitis induced morbidity/mortality
|
J:303079
|
Gm41610em1Scrp/Gm41610em1Scrp
(C57BL/6-Gm41610em1Scrp)
|
decreased susceptibility to endotoxin shock
|
J:302605
|
Gna11tm1Soff/Gna11tm1Soff
(involves: 129S7/SvEvBrd)
|
decreased susceptibility to type I hypersensitivity reaction
|
J:146132
|
Gna11tm1Soff/Gna11tm1Soff Gnaqtm2Soff/Gnaqtm2Soff Tg(Tek-icre/ERT2)1Soff/?
(involves: 129P2/OlaHsd * 129S7/SvEvBrd * FVB/N)
|
decreased susceptibility to type I hypersensitivity reaction
|
J:146132
|
Gpr31btm1Ktak/Gpr31btm1Ktak
(B6.Cg-Gpr31btm1Ktak)
|
decreased inflammatory response
|
J:271242
|
Gpr35tm1(KOMP)Vlcg/Gpr35tm1(KOMP)Vlcg
(C57BL/6N-Gpr35tm1(KOMP)Vlcg/MbpMmucd)
|
decreased susceptibility to colitis induced morbidity/mortality
|
J:306520
|
decreased susceptibility to induced colitis
|
J:306520
|
Gsntm1Djk/Gsntm1Djk
(either: (involves: 129S4/SvJae * BALB/c) or (involves: 129S4/SvJae * C57BL/6))
|
decreased inflammatory response
|
J:24346
|
Gt(ROSA)26Sortm1(B4galt1)Clib/Gt(ROSA)26Sortm1(B4galt1)Clib Tg(Nes-cre)Wme/?
(involves: 129S6/SvEvTac * C57BL/6 * CBA)
|
decreased acute inflammation
|
J:209737
|
decreased susceptibility to induced colitis
|
J:209737
|
Gt(ROSA)26Sortm1(CAG-CAMK2G*T287D,-EGFP)Whua/Gt(ROSA)26Sor+ Tg(Vil1-cre)997Gum/0
(involves: 129 * C57BL/6)
|
decreased susceptibility to induced colitis
|
J:243363
|
Gt(ROSA)26Sortm1(DTA)Jpmb/Gt(ROSA)26Sor+ Tg(Trpv1-cre)1Hoon/0
(involves: 129S1/Sv)
|
decreased inflammatory response
|
J:169256
|
H2-DMatm1Luc/H2-DMatm1Luc
(B6.129S4-H2-Dmatm1Luc)
|
decreased susceptibility to type IV hypersensitivity reaction
|
J:125654
|
Hif1atm3Rsjo/Hif1atm3Rsjo Lyz2tm1(cre)Ifo/Lyz2+
(involves: 129P2/OlaHsd * 129S1/Sv * 129X1/SvJ)
|
decreased inflammatory response
|
J:107682
|
Hif1atm3Rsjo/Hif1atm3Rsjo Lyz2tm1(cre)Ifo/Lyz2+
(involves: 129P2/OlaHsd * 129S1/Sv * 129X1/SvJ * C57BL/6)
|
decreased susceptibility to endotoxin shock
|
J:148597
|
Hmox1tm1.1Hes/Hmox1tm1.1Hes Lyz2tm1(cre)Ifo/Lyz2+
(involves: 129P2/OlaHsd * C57BL/6J * C57BL/6N)
|
decreased inflammatory response
|
J:214639
|
Hpsetm1.2Mdh/Hpsetm1.2Mdh
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
decreased acute inflammation
|
J:209913
|
Hrh1tm1Wtn/Hrh1tm1Wtn
(B6.129P2-Hrh1tm1Wtn)
|
decreased inflammatory response
|
J:110367
|
Hrh4tm1Lex/Hrh4tm1Lex
(involves: 129S/SvEv * BALB/c)
|
decreased inflammatory response
|
J:131785
|
Icam1tm1Bay/Icam1tm1Bay
(involves: 129S7/SvEvBrd * C57BL/6J)
|
decreased susceptibility to type IV hypersensitivity reaction
|
J:14565
|
Icam1tm1Bay/Icam1tm1Bay
(B6.129S7-Icam1tm1Bay)
|
decreased susceptibility to endotoxin shock
|
J:123460
|
Icam1tm1Bay/Icam1tm1Bay
(involves: 129S7/SvEvBrd * C57BL/6)
|
decreased susceptibility to induced colitis
|
J:111227
|
Icam1tm1Bay/Icam1tm1Bay Seletm2Alb/Seletm2Alb Selptm1Bay/Selptm1Bay
(involves: 129S7/SvEvBrd * C57BL/6)
|
decreased acute inflammation
|
J:112286
|
Icam1tm1Jcgr/Icam1tm1Jcgr
(involves: 129S4/SvJae * C57BL/6 * DBA/2)
|
decreased susceptibility to type IV hypersensitivity reaction
|
J:18743
|
Icosltm1Mak/Icosltm1Mak
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased inflammatory response
|
J:84668
|
Ido1tm1Alm/Ido1tm1Alm
(involves: 129X1/SvJ * C57BL/6J * FVB/N)
|
decreased susceptibility to type IV hypersensitivity reaction
|
J:211949
|
Ido2em1Lamn/Ido2em1Lamn
(involves: BALB/c * C57BL/6J)
|
decreased susceptibility to type IV hypersensitivity reaction
|
J:342726
|
Ido2em2Lamn/Ido2em2Lamn
(involves: BALB/c * C57BL/6J)
|
decreased susceptibility to type IV hypersensitivity reaction
|
J:342726
|
Ido2tm1.2Gcp/Ido2tm1.2Gcp
(involves: C57BL/6J * FVB/N)
|
decreased susceptibility to type IV hypersensitivity reaction
|
J:211949
|
Ier3tm1Mxw/Ier3tm1Mxw
(involves: C57BL/6)
|
decreased susceptibility to induced colitis
|
J:194587
|
Ier3tm1Mxw/Ier3tm1Mxw Rag1tm1Mom/Rag1tm1Mom
(involves: 129S7/SvEvBrd * C57BL/6)
|
decreased susceptibility to induced colitis
|
J:194587
|
Ifi35em1Hhl/Ifi35em1Hhl
(C57BL/6-Ifi35em1Hhl)
|
decreased susceptibility to endotoxin shock
|
J:298909
|
Ifi204tm1.1Cjul/Ifi204tm1.1Cjul
(B6.129(Cg)-Ifi204tm1.1Cjul)
|
decreased susceptibility to endotoxin shock
|
J:270123
|
Ifngtm1Ts/Ifngtm1Ts
(involves: 129S7/SvEvBrd)
|
decreased susceptibility to type IV hypersensitivity reaction
|
J:29170
|
Ifngtm1Ts/Ifngtm1Ts
(involves: 129S7/SvEvBrd * BALB/c)
|
decreased inflammatory response
|
J:114213
|
Ifngtm1Yiw/Ifngtm1Yiw
(involves: 129X1/SvJ * C57BL/6)
|
decreased inflammatory response
|
J:41632,
J:88226
|
Ifngr1tm1Agt/Ifngr1tm1Agt
(involves: 129S7/SvEvBrd)
|
decreased susceptibility to endotoxin shock
|
J:17878
|
Ifngr2tm1Pbro/Ifngr2tm1Pbro
(involves: 129S1/Sv)
|
decreased susceptibility to type IV hypersensitivity reaction
|
J:48016
|
Igf1rtm1Jcbr/Igf1rtm1Jcbr Ndor1Tg(UBC-cre/ERT2)1Ejb/0
(B6.Cg-Ndor1Tg(UBC-cre/ERT2)1Ejb Igf1rtm1Jcbr)
|
decreased susceptibility to type I hypersensitivity reaction
|
J:241924
|
Ighmtm1Cgn/Ighmtm1Cgn
(involves: 129S2/SvPas)
|
decreased susceptibility to type IV hypersensitivity reaction
|
J:112160
|
Ikbkbtm2Mka/Ikbkbtm2.1Mka Tg(Vil-cre)1Mka/0
(involves: 129/Sv * C57BL/6)
|
decreased acute inflammation
|
J:83313
|
Ikbkgtm1Dwb/Ikbkgtm1Dwb
(Not Specified)
|
decreased susceptibility to endotoxin shock
|
J:136353
|
Il1atm1Yiw/Il1atm1Yiw Il1btm1Yiw/Il1btm1Yiw
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
decreased susceptibility to type IV hypersensitivity reaction
|
J:165513
|
Il1btm1Dch/Il1btm1Dch
(involves: 129S2/SvPas)
|
decreased susceptibility to type IV hypersensitivity reaction
|
J:33465
|
Il1btm1Lvp/Il1btm1Lvp
(involves: 129S7/SvEvBrd * C57BL/6)
|
decreased acute inflammation
|
J:27234
|
decreased inflammatory response
|
J:27234
|
Il1r1tm1Roml/Il1r1tm1Roml
(involves: 129S1/Sv * C57BL/6)
|
decreased susceptibility to type IV hypersensitivity reaction
|
J:42373
|
Il1rl2tm1Hblu/Il1rl2tm1Hblu
(involves: 129)
|
decreased susceptibility to induced colitis
|
J:256437
|
Il3tm1Glli/Il3tm1Glli
(either: (involves: 129S2/SvPas * BALB/c) or (involves: 129S2/SvPas * C57BL/6))
|
decreased susceptibility to type IV hypersensitivity reaction
|
J:80640
|
Il4/Il13tm3Anjm/Il4/Il13tm3Anjm
(involves: 129P2/OlaHsd * BALB/c)
|
decreased inflammatory response
|
J:60609,
J:165513
|
Il4/Il13tm3Anjm/Il4/Il13tm3Anjm
(involves: 129P2/OlaHsd * BALB/c)
|
decreased inflammatory response
|
J:60609,
J:165513
|
Il6tm1Kopf/Il6tm1Kopf Il6sttm1Ern/Il6sttm1Ern
(involves: 129S1/Sv * 129S2/SvPas)
|
decreased susceptibility to endotoxin shock
|
J:168781
|
Il6tm1Poli/Il6tm1Poli
(involves: 129S/SvEv * C57BL/6)
|
decreased inflammatory response
|
J:68063
|
Il6tm1Poli/Il6tm1Poli
(CAnNCrl.129S(Cg)-Il6tm1Poli)
|
decreased inflammatory response
|
J:42869
|
Il6ratm1.1Drew/Il6ratm1.1Drew Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: C57BL/6 * C57BL/6N * SJL)
|
decreased acute inflammation
|
J:160966
|
Il6sttm1Ern/Il6sttm1Ern
(involves: 129S1/Sv * C57BL/6)
|
decreased susceptibility to induced colitis
|
J:79073
|
Il6sttm1Ern/Il6sttm1Ern Stat3tm1Aki/Stat3+
(involves: 129P2/OlaHsd * 129S1/Sv)
|
decreased susceptibility to endotoxin shock
|
J:168781
|
Il6sttm1Ern/Il6sttm1Ern Tiraptm1.1Pjh/Tiraptm1.1Pjh
(involves: 129S1/Sv)
|
decreased susceptibility to endotoxin shock
|
J:168781
|
Il10tm1Cgn/Il10tm1Cgn Il27ratm1Mak/Il27ratm1Mak
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased susceptibility to induced colitis
|
J:136179
|
Il12atm1Jm/Il12atm1Jm
(129S1/Sv-Il12atm1Jm)
|
decreased susceptibility to type IV hypersensitivity reaction
|
J:34164
|
Il12btm1Jm/Il12btm1Jm
(B6.129S1-Il12btm1Jm/J)
|
decreased susceptibility to type IV hypersensitivity reaction
|
J:120806
|
Il12btm1Jm/Il12btm1Jm
(129S1/Sv-Il12btm1Jm)
|
decreased susceptibility to type IV hypersensitivity reaction
|
J:34164
|
Il13ra2tm1Gru/Il13ra2tm1Gru
(C.Cg-Il13ra2tm1Gru)
|
decreased susceptibility to endotoxin shock
|
J:82376
|
Il15tm1Imx/Il15tm1Imx
(involves: C57BL/6)
|
decreased susceptibility to type IV hypersensitivity reaction
|
J:87137
|
Il17atm1Yiw/Il17atm1Yiw
(involves: 129P2/OlaHsd * C57BL/6J)
|
decreased susceptibility to type IV hypersensitivity reaction
|
J:79127
|
Il17atm1Yiw/Il17atm1Yiw
(involves: 129P2/OlaHsd * BALB/cA * C57BL/6J)
|
decreased susceptibility to type IV hypersensitivity reaction
|
J:79127
|
Il17ftm1Cdon/Il17ftm1Cdon
(involves: C57BL/6)
|
decreased acute inflammation
|
J:136279
|
decreased susceptibility to induced colitis
|
J:136279
|
Il17ratm1Koll/Il17ratm1Koll
(involves: 129 * C57BL/6)
|
decreased inflammatory response
|
J:139080
|
Il17rbtm1Bud/Il17rbtm1Bud
(B6.129-Il17rbtm1Bud)
|
decreased inflammatory response
|
J:139080
|
Il17rbtm1Tgi/Il17rb+
(Not Specified)
|
decreased susceptibility to induced colitis
|
J:229778
|
Il17rbtm1Tgi/Il17rbtm1Tgi
(Not Specified)
|
decreased susceptibility to induced colitis
|
J:229778
|
Il17rctm1Lex/Il17rctm1Lex
(involves: C57BL/6)
|
decreased inflammatory response
|
J:159874
|
Il18tm1Khe/Il18tm1Khe
(involves: 129P2/OlaHsd)
|
decreased susceptibility to endotoxin shock
|
J:62263
|
Il21rtm1Day/Il21rtm1Day
(involves: BALB/c * C57BL/6)
|
decreased susceptibility to type IV hypersensitivity reaction
|
J:144708
|
Il23atm1Ngh/Il23atm1Ngh
(involves: 129 * C57BL/6)
|
decreased susceptibility to induced colitis
|
J:216867
|
Il23rtm1.1Ngh/Il23rtm1.1Ngh
(involves: C57BL/6)
|
decreased susceptibility to induced colitis
|
J:216867
|
Il25tm1.1Cdon/Il25tm1.1Cdon
(involves: 129S6/SvEvTac)
|
decreased susceptibility to induced colitis
|
J:229778
|
Il25tm1Cdon/Il25tm1Cdon Tg(Vil1-cre)997Gum/0
(involves: 129S6/SvEvTac * C57BL/6J * C57BL/6N * SJL)
|
decreased susceptibility to induced colitis
|
J:229778
|
Il33tm1Snak/Il33tm1Snak
(involves: C57BL/6 * CBA)
|
decreased inflammatory response
|
J:165513
|
decreased susceptibility to endotoxin shock
|
J:165513
|
Il34tm1b(EUCOMM)Wtsi/Il34tm1b(EUCOMM)Wtsi
(involves: BALB/cJ * C57BL/6N)
|
decreased susceptibility to type IV hypersensitivity reaction
|
J:187643
|
Il36gtm1Lex/Il36gtm1Lex
(involves: 129S5/SvEvBrd)
|
decreased susceptibility to induced colitis
|
J:256437
|
Irak1tm1Jth/Y Irak2tm1Aki/Irak2tm1Aki
(involves: 129/Sv * C57BL/6)
|
decreased susceptibility to endotoxin shock
|
J:136290
|
Irak2tm1Aki/Irak2tm1Aki
(involves: 129/Sv * C57BL/6)
|
decreased susceptibility to endotoxin shock
|
J:136290
|
Irak2tm1Jth/Irak2tm1Jth
(involves: 129 * C57BL/6)
|
decreased susceptibility to endotoxin shock
|
J:149258
|
Irak4tm1Aki/Irak4tm1Aki
(involves: 129X1/SvJ * C57BL/6)
|
decreased susceptibility to endotoxin shock
|
J:125729
|
Irak4tm1Lix/Irak4tm1Lix
(involves: C57BL/6)
|
decreased acute inflammation
|
J:125732
|
decreased susceptibility to endotoxin shock
|
J:125732
|
Irak4tm1Yeh/Irak4tm1Yeh
(involves: 129P2/OlaHsd * C57BL/6J)
|
decreased susceptibility to endotoxin shock
|
J:76098
|
Irak4tm2Aki/Irak4tm2Aki
(involves: 129X1/SvJ * C57BL/6)
|
decreased susceptibility to endotoxin shock
|
J:125729
|
Itgaltm1Mak/Itgal+
(B6.129P2-Itgaltm1Mak)
|
decreased susceptibility to endotoxin shock
|
J:123460
|
Itgaltm1Mak/Itgaltm1Mak
(B6.129P2-Itgaltm1Mak)
|
decreased susceptibility to endotoxin shock
|
J:123460
|
Itgb2tm1Bay/Itgb2tm1Bay
(involves: 129S7/SvEvBrd)
|
decreased inflammatory response
|
J:13599
|
Itgb2tm2Bay/Itgb2tm2Bay
(involves: 129S7/SvEvBrd * C57BL/6)
|
decreased acute inflammation
|
J:112286
|
Itgb2tm2Bay/Itgb2tm2Bay
(PL.129S7-Itgb2tm2Bay)
|
decreased susceptibility to type IV hypersensitivity reaction
|
J:109598
|
Jmjd8em1Kaso/Jmjd8em1Kaso
(C57BL/6-Jmjd8em1Kaso)
|
decreased inflammatory response
|
J:319518
|
Kif1cOrch3-BALB/cByJ/Kif1cOrch3-DBA/2J
(involves: BALB/cByJ * DBA/2)
|
decreased inflammatory response
|
J:35331
|
Kif1cOrch3-DBA/2J/Kif1cOrch3-DBA/2J
(involves: BALB/cByJ * DBA/2)
|
decreased inflammatory response
|
J:35331
|
KitW-sh/KitW-sh
(involves: C57BL/6J)
|
decreased susceptibility to type I hypersensitivity reaction
|
J:197334
|
KitW-sh/KitW-sh
(B6.Cg-KitW-sh/HNihrJaeBsmGlliJ)
|
decreased susceptibility to type I hypersensitivity reaction
|
J:275367
|
KitW/KitW-v
((WB/ReJ x C57BL/6J-KitW-v/J)F1-KitW/KitW-v/J)
|
decreased inflammatory response
|
J:131785
|
KitW/KitW-v
((WB KitW x B6.Cg-KitW-v)F1)
|
decreased susceptibility to type I hypersensitivity reaction
|
J:197334
|
Klhdc10tm1Hijo/Klhdc10tm1Hijo
(B6J.B6N-Klhdc10tm1Hijo)
|
decreased inflammatory response
|
J:251158
|
Klk6tm1Gsot/Klk6+
(involves: C57BL/6)
|
decreased inflammatory response
|
J:270051
|
Klk6tm1Gsot/Klk6tm1Gsot
(involves: C57BL/6)
|
decreased inflammatory response
|
J:270051
|
Klk6tm1Gsot/Klk6tm1Gsot Spink5tm1Drh/Spink5tm1Drh
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased inflammatory response
|
J:289877
|
Lacc1em1Arkr/Lacc1em1Arkr
(C57BL/6NTac-Lacc1em1Arkr)
|
decreased susceptibility to endotoxin shock
|
J:244365
|
Lacc1em2Arkr/Lacc1em2Arkr
(C57BL/6NTac-Lacc1em2Arkr)
|
decreased susceptibility to endotoxin shock
|
J:244365
|
Lbptm1Buru/Lbptm1Buru
(involves: 129S1/Sv * 129X1/SvJ * BALB/c)
|
decreased susceptibility to type I hypersensitivity reaction
|
J:67090
|
Litaftm1Samr/Litaftm1Samr
(involves: 129S4/SvJae)
|
decreased susceptibility to endotoxin shock
|
J:113750
|
Loxl2tm1.2Acan/Loxl2tm1.2Acan
(Not Specified)
|
decreased inflammatory response
|
J:220689
|
Lta4htm1Bhk/Lta4htm1Bhk
(involves: 129P2/OlaHsd * 129S/SvEv)
|
decreased acute inflammation
|
J:58985
|
decreased susceptibility to type I hypersensitivity reaction
|
J:58985
|
Lta/Tnftm1Fda/Lta/Tnftm1Fda
(involves: 129S1/Sv * 129X1/SvJ)
|
decreased susceptibility to endotoxin shock
|
J:39519
|
Lta/Tnftm1Fda/Lta+
(involves: 129S1/Sv * 129X1/SvJ)
|
decreased susceptibility to endotoxin shock
|
J:39519
|
Lta/Tnftm1Fda/Lta/Tnftm1Fda
(involves: 129S1/Sv * 129X1/SvJ)
|
decreased susceptibility to endotoxin shock
|
J:39519
|
Lta/Tnftm1Fda/Tnf+
(involves: 129S1/Sv * 129X1/SvJ)
|
decreased susceptibility to endotoxin shock
|
J:39519
|
Ltb4r1tm1Tksh/Ltb4r1tm1Tksh
(B6.Cg-Ltb4r1tm1Tksh)
|
decreased susceptibility to type I hypersensitivity reaction
|
J:197334
|
Ltb4r2tm1Tksh/Ltb4r2tm1Tksh
(B6.Cg-Ltb4r2tm1Tksh)
|
decreased susceptibility to type I hypersensitivity reaction
|
J:197334
|
Ltc4stm1Blam/Ltc4stm1Blam
(B6.129S7-Ltc4stm1Blam)
|
decreased susceptibility to type I hypersensitivity reaction
|
J:197334
|
Ly6etm1c(EUCOMM)Hmgu/Ly6etm1c(EUCOMM)Hmgu Commd10Tg(Vav1-icre)A2Kio/Commd10+
(B6.Cg-Ly6etm1c(EUCOMM)Hmgu Commd10Tg(Vav1-icre)A2Kio)
|
decreased inflammatory response
|
J:291868
|
Ly96tm1Kmiy/Ly96tm1Kmiy
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased susceptibility to endotoxin shock
|
J:92494
|
Map3k8tm1Pnt/Map3k8tm1Pnt
(involves: 129S1/Sv * C57BL/6J)
|
decreased susceptibility to endotoxin shock
|
J:66503
|
Mapk8tm1Rjd/Mapk8tm1Rjd Mapk9tm2.1Rjd/Mapk9tm2.1Rjd Lyz2tm1(cre)Ifo/Lyz2+
(B6J.Cg-Lyz2tm1(cre)Ifo Mapk9tm2.1Rjd Mapk8tm1Rjd)
|
decreased inflammatory response
|
J:192551
|
Mapkapk2tm1Mgl/Mapkapk2tm1Mgl
(involves: 129P2/OlaHsd * C57BL/6J)
|
decreased susceptibility to endotoxin shock
|
J:59678
|
Mcl1tm3Sjk/Mcl1tm3Sjk Tg(Cpa3-cre)3Glli/0
(involves: 129X1/Sv * C57BL/6)
|
decreased inflammatory response
|
J:179080
|
decreased susceptibility to type I hypersensitivity reaction
|
J:179080
|
Mep1btm1Bond/Mep1btm1Bond
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
decreased inflammatory response
|
J:132021
|
Miftm1Dvd/Miftm1Dvd
(involves: 129S4/SvJae * C57BL/6)
|
decreased susceptibility to endotoxin shock
|
J:52300
|
Mir511em1Clib/Mir511em1Clib
(C57BL/6J-Mir511em1Clib)
|
decreased susceptibility to induced colitis
|
J:345580
|
Mlklm1Btlr/Mlkl+
(C57BL/6J-Mlklm1Btlr)
|
decreased inflammatory response
|
J:225934
|
Mlklm1Btlr/Mlklm1Btlr
(C57BL/6J-Mlklm1Btlr)
|
decreased inflammatory response
|
J:225934
|
Mlklm2Btlr/Mlkl+
(C57BL/6J-Mlklm2Btlr)
|
decreased inflammatory response
|
J:234252
|
Mlklm2Btlr/Mlklm2Btlr
(C57BL/6J-Mlklm2Btlr)
|
decreased inflammatory response
|
J:234252
|
Mlklm3Btlr/Mlkl+
(C57BL/6J-Mlklm3Btlr)
|
decreased inflammatory response
|
J:234251
|
Mlklm3Btlr/Mlklm3Btlr
(C57BL/6J-Mlklm3Btlr)
|
decreased inflammatory response
|
J:234251
|
Mmp1atm1Otin/Mmp1atm1Otin
(involves: 129P2/OlaHsd * C57BL/6J)
|
decreased inflammatory response
|
J:198586
|
Mmp2tm1Ito/Mmp2tm1Ito
(involves: 129P2/OlaHsd * C57BL/6J)
|
decreased inflammatory response
|
J:46091
|
Mmp3tm1Mrl/Mmp3tm1Mrl
(involves: 129S7/SvEvBrd * C57BL/10ScSn * RIII)
|
decreased susceptibility to type IV hypersensitivity reaction
|
J:55723
|
Mmp9tm1Tvu/Mmp9tm1Tvu
(involves: 129S6/SvEvTac)
|
decreased inflammatory response
|
J:84293
|
Mmp9tm1Tvu/Mmp9tm1Tvu
(FVB.129S6-Mmp9tm1Tvu)
|
decreased susceptibility to induced colitis
|
J:104644
|
Mmp19tm1Rase/Mmp19tm1Rase
(B6.129P2-Mmp19tm1Rase)
|
decreased inflammatory response
|
J:137128
|
decreased susceptibility to type IV hypersensitivity reaction
|
J:137128
|
Mpotm1Lus/Mpotm1Lus
(involves: 129X1/SvJ * C57BL/6J)
|
decreased inflammatory response
|
J:102688
|
Mrgprb2em1Xzd/Mrgprb2em1Xzd
(C57BL/6-Mrgprb2em1Xzd)
|
decreased inflammatory response
|
J:219209
|
Mrs2em1Muma/Mrs2em1Muma
(B6.Cg-Mrs2em1Muma)
|
decreased susceptibility to endotoxin shock
|
J:298361
|
Ms4a2tm1Chr/Ms4a2tm1Chr
(involves: 129S1/Sv * 129X1/SvJ)
|
decreased susceptibility to type I hypersensitivity reaction
|
J:53106
|
Ms4a2tm1Knt/Ms4a2tm1Knt
(involves: 129 * BALB/c)
|
decreased susceptibility to type I hypersensitivity reaction
|
J:47138
|
Ms4a2tm1Knt/Ms4a2tm1Knt Tg(SV40/HTLV-FCER1A)1Bhk/0
(involves: 129 * BALB/c)
|
decreased susceptibility to type I hypersensitivity reaction
|
J:47138
|
Muc4tm1Skb/Muc4tm1Skb
(involves: 129 * C57BL/6J)
|
decreased susceptibility to colitis induced morbidity/mortality
|
J:234205
|
decreased susceptibility to induced colitis
|
J:234205
|
Mxra8em1Diam/Mxra8em1Diam
(C57BL/6J-Mxra8em1Diam)
|
decreased inflammatory response
|
J:280585
|
Myd88tm1Aki/Myd88tm1Aki
(B6.129P2-Myd88tm1Aki)
|
decreased inflammatory response
|
J:123946
|
Mydgftm1Kcw/Mydgftm1Kcw
(BALB/c-Mydgftm1Kcw)
|
decreased inflammatory response
|
J:216795
|
Naipctm1.1Kmma/Naipctm1.1Kmma
(involves: BALB/cJ * C57BL/6)
|
decreased susceptibility to induced colitis
|
J:222114
|
Naipctm1Kmma/Naipctm1Kmma Lyz2tm1(cre)Ifo/Lyz2+
(B6.Cg-Lyz2tm1(cre)Ifo Naipctm1Kmma)
|
decreased susceptibility to induced colitis
|
J:222114
|
Naipctm1Kmma/Naipctm1Kmma Tg(Vil1-cre)997Gum/0
(B6.Cg-Naipctm1Kmma Tg(Vil1-cre)997Gum)
|
decreased susceptibility to induced colitis
|
J:222114
|
Nbr1tm1.1Jmos/Nbr1tm1.1Jmos Tnfrsf4tm2(cre)Nik/Tnfrsf4+
(involves: 129X1/SvJ * C57BL/6J)
|
decreased inflammatory response
|
J:165438
|
Ncapd2em1Cya/Ncapd2+
(C57BL/6N-Ncapd2em1Cya)
|
decreased susceptibility to induced colitis
|
J:310248
|
Ndrg2tm1.1Hori/Ndrg2tm1.1Hori
(B6.129-Ndrg2tm1.1Hori)
|
decreased inflammatory response
|
J:214686
|
Ndst1tm1Je/Ndst1tm1Je Tg(Tek-cre)1Ywa/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * SJL)
|
decreased inflammatory response
|
J:100456
|
Nek7M1Btlr/Nek7+
(C57BL/6J-Nek7M1Btlr)
|
decreased inflammatory response
|
J:226677
|
Nek7M1Btlr/Nek7M1Btlr
(C57BL/6J-Nek7M1Btlr)
|
decreased inflammatory response
|
J:226677
|
Nfkbibtm1Bal/Nfkbibtm1Bal
(B6.129S1-Nfkbibtm1Bal)
|
decreased susceptibility to endotoxin shock
|
J:163302
|
Nlrc4em1Vnce/Nlrc4em1Vnce
(C57BL/6-Nlrc4em1Vnce)
|
decreased inflammatory response
|
J:294930
|
Nlrc4em1Vnce/Nlrc4em1Vnce Nlrp3tm1Vmd/Nlrp3tm1Vmd
(involves: C57BL/6J * C57BL/6N)
|
decreased inflammatory response
|
J:294930
|
Nlrc4em2Vnce/Nlrc4em2Vnce
(C57BL/6-Nlrc4em2Vnce)
|
decreased inflammatory response
|
J:294930
|
Nlrc4em2Vnce/Nlrc4em2Vnce Nlrp3tm1Vmd/Nlrp3tm1Vmd
(involves: C57BL/6J * C57BL/6N)
|
decreased inflammatory response
|
J:294930
|
Nlrp3tm1Flv/Nlrp3tm1Flv
(involves: 129S5/SvEvBrd * C57BL/6)
|
decreased susceptibility to endotoxin shock
|
J:113333
|
decreased susceptibility to type IV hypersensitivity reaction
|
J:113333
|
Nlrp3tm1Flv/Nlrp3tm1Flv
(involves: 129S5/SvEvBrd)
|
decreased susceptibility to induced colitis
|
J:173245
|
Nlrp3tm1Vmd/Nlrp3tm1Vmd
(involves: C57BL/6N)
|
decreased susceptibility to endotoxin shock
|
J:106976
|
Nlrp3tm1Vmd/Nlrp3tm1Vmd
(B6.B6N-Nlrp3tm1Vmd)
|
decreased susceptibility to endotoxin shock
|
J:193522
|
Nlrp10tm1Seis/Nlrp10tm1Seis
(B6.Cg-Nlrp10tm1Seis)
|
decreased susceptibility to endotoxin shock
|
J:183989
|
Nlrp12tm1Jpyt/Nlrp12tm1Jpyt
(B6.Cg-Nlrp12tm1Jpyt)
|
decreased susceptibility to type IV hypersensitivity reaction
|
J:164725
|
Nmiem1Hhl/Nmiem1Hhl
(C57BL/6-Nmiem1Hhl)
|
decreased susceptibility to endotoxin shock
|
J:298909
|
Nmt1tm1.1Poru/Nmt1tm1.1Poru Nmt2tm1.1Poru/Nmt2tm1.1Poru Tg(Lck-cre)1Cwi/0
(involves: C57BL/6 * DBA/2 * SJL)
|
decreased susceptibility to endotoxin shock
|
J:226234
|
Nod2tm1Flv/Nod2tm1Flv
(involves: 129S1/Sv * C57BL/6)
|
decreased susceptibility to endotoxin shock
|
J:96035
|
Nod2tm1Pmu/Nod2tm1Pmu
(involves: BALB/c * C57BL/6)
|
decreased susceptibility to endotoxin shock
|
J:86264
|
Nos1tm1Plh/Nos1tm1Plh
(B6.129S4-Nos1tm1Plh/J)
|
decreased inflammatory response
|
J:103018
|
Nos2tm1Lau/Nos2tm1Lau
(B6.129P2-Nos2tm1Lau)
|
decreased susceptibility to induced colitis
|
J:87601
|
Nos2tm1Lau/Nos2tm1Lau
(B6.129P2-Nos2tm1Lau/J)
|
decreased inflammatory response
|
J:103018
|
Nos2tm1Liew/Nos2tm1Liew
(involves: 129P2/Ola * MF1)
|
decreased inflammatory response
|
J:25755
|
decreased susceptibility to endotoxin shock
|
J:25755
|
Nos2tm1Mrl/Nos2tm1Mrl
(involves: 129S7/SvEvBrd)
|
decreased susceptibility to endotoxin shock
|
J:25511
|
Nox4tm1Syb/Nox4tm1Syb
(involves: 129S4/SvJae)
|
decreased susceptibility to endotoxin shock
|
J:298830
|
Npy1rtm1.1Wpg/Npy1rtm1.1Wpg
(involves: 129X1/SvJ * C57BL/6)
|
decreased susceptibility to type IV hypersensitivity reaction
|
J:118850
|
Nr1h3tm1Wexi/Nr1h3tm1Wexi
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)
|
decreased susceptibility to endotoxin shock
|
J:155709
|
Nr2c2tm1Amj/Nr2c2tm1Amj
(B6.129-Nr2c2tm1Amj)
|
decreased inflammatory response
|
J:169333
|
Nsmaftm1Mkr/Nsmaftm1Mkr
(B6.129P2-Nsmaftm1Mkr)
|
decreased susceptibility to endotoxin shock
|
J:89524
|
Orai1Gt(XL922)Byg/Orai1Gt(XL922)Byg
(involves: 129P2/OlaHsd * C57BL/6 * DBA/2)
|
decreased susceptibility to type I hypersensitivity reaction
|
J:130479
|
Orch4BALB/cByJ/Orch4DBA/2J
(involves: BALB/cByJ * DBA/2)
|
decreased inflammatory response
|
J:35331
|
Orch4DBA/2J/Orch4DBA/2J
(involves: BALB/cByJ * DBA/2)
|
decreased inflammatory response
|
J:35331
|
Orch5BALB/cByJ/Orch5DBA/2J
(involves: BALB/cByJ * DBA/2)
|
decreased inflammatory response
|
J:35331
|
Orch5DBA/2J/Orch5DBA/2J
(involves: BALB/cByJ * DBA/2)
|
decreased inflammatory response
|
J:35331
|
Parp1tm1Zqw/Parp1tm1Zqw
(involves: 129/Sv * C57BL/6)
|
decreased inflammatory response
|
J:94497
|
Parp1tm1Zqw/Parp1tm1Zqw
(129S-Parp1tm1Zqw/J)
|
decreased inflammatory response
|
J:95418
|
Parp1tm2Zqw/Parp1tm2Zqw
(either: (involves: 129P2/OlaHsd * 129/Sv) or (involves: 129P2/OlaHsd * C57BL/6))
|
decreased inflammatory response
|
J:93479
|
decreased susceptibility to endotoxin shock
|
J:93479
|
Peli1tm1Tigm/Peli1tm1Tigm
(involves: 129/Sv * C57BL/6)
|
decreased susceptibility to endotoxin shock
|
J:152781
|
Pgam1tm1.1Hiko/Pgam1tm1.1Hiko Tg(Cd4-cre)1Cwi/0
(involves: C57BL/6 * DBA/2)
|
decreased acute inflammation
|
J:293746
|
Pgftm1Pec/Pgftm1Pec
(involves: 129)
|
decreased susceptibility to type IV hypersensitivity reaction
|
J:81388
|
Pgia39DBA/2Crl/? Pgia6BALB/cCrl/Pgia6DBA/2Crl
(involves: BALB/cCrl * DBA/2Crl)
|
decreased inflammatory response
|
J:84150
|
Phlpp1tm1.1Saco/Phlpp1tm1.1Saco Phlpp2tm1d(EUCOMM)Hmgu/Phlpp2tm1d(EUCOMM)Hmgu
(involves: 129 * C57BL/6N)
|
decreased susceptibility to induced colitis
|
J:231241
|
Pik3cdtm1Tnr/Pik3cdtm1Tnr
(B6.129S4-Pik3cdtm1Tnr)
|
decreased inflammatory response
|
J:134324
|
Pik3cdtm1Tnr/Pik3cdtm1Tnr Pik3cgtm1Pngr/Pik3cgtm1Pngr
(B6.129-Pik3cdtm1Tnr Pik3cgtm1Pngr)
|
decreased inflammatory response
|
J:134324
|
Pik3cgtm1Pngr/Pik3cgtm1Pngr
(B6.129P2-Pik3cgtm1Pngr)
|
decreased inflammatory response
|
J:134324
|
Pla2g3tm1Murm/Pla2g3tm1Murm
(involves: 129S/SvEv * C57BL/6)
|
decreased susceptibility to type I hypersensitivity reaction
|
J:197334
|
Pla2g5tm1Jarm/Pla2g5tm1Jarm
(involves: 129 * C57BL/6J)
|
decreased acute inflammation
|
J:89490
|
Pla2g10Gt712Lex/Pla2g10Gt712Lex
(involves: 129S5/SvEvBrd * C57BL/6J)
|
decreased inflammatory response
|
J:125607
|
Pla2r1tm1Itoh/Pla2r1tm1Itoh
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased susceptibility to endotoxin shock
|
J:44868
|
Plautm1Mlg/Plautm1Mlg
(B6.Cg-Plautm1Mlg)
|
decreased inflammatory response
|
J:68083
|
Plin2tm1.1Asg/Plin2tm1.1Asg
(B6.129S2(Cg)-Plin2tm1.1Asg)
|
decreased inflammatory response
|
J:196302
|
Prkar1btm1Gsm/Prkar1btm1Gsm
(Not Specified)
|
decreased inflammatory response
|
J:43080
|
Prkcgtm1Stl/Prkcgtm1Stl
(Not Specified)
|
decreased inflammatory response
|
J:25061
|
Prss34tm1.1Hkar/Prss34tm1.1Hkar
(involves: C57BL/6)
|
decreased inflammatory response
|
J:238924
|
Ptafrtm1Tksh/Ptafrtm1Tksh
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased inflammatory response
|
J:87866
|
Ptgdr2tm1Tasa/Ptgdr2tm1Tasa
(C.129-Ptgdr2tm1Tasa)
|
decreased inflammatory response
|
J:131146
|
decreased susceptibility to type IV hypersensitivity reaction
|
J:131146
|
Ptgdrtm1Sna/Ptgdrtm1Sna
(B6.129P2-Ptgdrtm1Sna/Sna)
|
decreased susceptibility to type I hypersensitivity reaction
|
J:197334
|
Ptgdstm1Ohy/Ptgdstm1Ohy
(B6.129P2-Ptgdstm1Ohy)
|
decreased susceptibility to type I hypersensitivity reaction
|
J:197334
|
Ptger1tm1Sna/Ptger1tm1Sna
(B6CrSlc.129P2-Ptger1tm1Sna/Sna)
|
decreased susceptibility to type IV hypersensitivity reaction
|
J:128435
|
Ptger2tm1.1Kand/Ptger2tm1.1Kand Tg(ITGAM-cre)2781Gkl/0
(involves: C57BL/6 * CBA)
|
decreased susceptibility to endotoxin shock
|
J:202677
|
Ptger4tm1Sna/Ptger4tm1Sna
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased susceptibility to type IV hypersensitivity reaction
|
J:83725
|
Ptgestm1Lpa/Ptgestm1Lpa
(DBA/1LacJ-Ptgestm1Lpa)
|
decreased inflammatory response
|
J:89960,
J:90980
|
Ptgirtm1Sna/Ptgirtm1Sna
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased acute inflammation
|
J:42275
|
Ptgs1tm1Fun/Ptgs1tm1Fun
(involves: 129S6/SvEvTac * C57BL/6)
|
decreased inflammatory response
|
J:97351
|
Ptgs1tm1Unc/Ptgs1tm1Unc
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased inflammatory response
|
J:29511
|
Ptgs2tm1Unc/Ptgs2tm1Unc
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased susceptibility to endotoxin shock
|
J:75611
|
Ptk2btm1Schl/Ptk2btm1Schl
(involves: 129S1/Sv * 129X1/SvJ)
|
decreased acute inflammation
|
J:99741
|
Ptprctm1Mak/Ptprctm1Mak
(involves: 129)
|
decreased susceptibility to type I hypersensitivity reaction
|
J:110782
|
Pycardtm1Flv/Pycardtm1Flv
(involves: 129S5/SvEvBrd * C57BL/6)
|
decreased susceptibility to endotoxin shock
|
J:113333
|
decreased susceptibility to type IV hypersensitivity reaction
|
J:113333
|
Pycardtm1Tno/Pycardtm1Tno
(involves: 129S4/SvJae * C57BL/6)
|
decreased susceptibility to endotoxin shock
|
J:100807
|
Pycardtm1Vmd/Pycardtm1Vmd
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6N)
|
decreased inflammatory response
|
J:91292
|
Pycardtm1Vmd/Pycardtm1Vmd
(B6.129-Pycardtm1Vmd)
|
decreased susceptibility to endotoxin shock
|
J:193522
|
Rac1tm1Djk/Rac1tm1.1Djk Lyz2tm1(cre)Ifo/Lyz2+
(involves: 129P2/OlaHsd * 129S4/SvJae * C57BL/6)
|
decreased acute inflammation
|
J:83457
|
Rad50tm2.1Flv/Rad50tm2.2Flv Tg(Cd4-cre)1Cwi/0
(involves: 129S6/SvEvTac * C57BL/6 * DBA/2)
|
decreased inflammatory response
|
J:165055
|
Rag1tm1Mom/Rag1tm1Mom
(involves: 129S7/SvEvBrd * C57BL/6)
|
decreased susceptibility to induced colitis
|
J:194587
|
Rag1tm1Mom/Rag1tm1Mom
(involves: 129S7/SvEvBrd)
|
decreased inflammatory response
|
J:94420
|
Rag1tm1Mom/Rag1tm1Mom Tg(CAG-Lyn*)#Paau/0
(involves: 129S7/SvEvBrd * C57BL/6)
|
decreased inflammatory response
|
J:151886
|
Rag2tm1Fwa/Rag2tm1Fwa
(involves: 129S/SvEv * C57BL/6)
|
decreased susceptibility to type IV hypersensitivity reaction
|
J:165513
|
Rasgrp4tm1(cre)Rls/Rasgrp4tm1(cre)Rls
(C57BL/6-Rasgrp4tm1(cre)Rls)
|
decreased susceptibility to induced colitis
|
J:186519
|
Relbtm1Brv/Relbtm1Brv
(involves: 129S2/SvPas * C57BL/6)
|
decreased susceptibility to type IV hypersensitivity reaction
|
J:22675
|
Retnlatm1Mer/Retnlatm1Mer
(C57BL/6-Retnlatm1Mer)
|
decreased susceptibility to induced colitis
|
J:144784,
J:144927
|
Retnlatm1Mer/Retnlatm1Mer
(C.B6-Retnlatm1Mer)
|
decreased susceptibility to induced colitis
|
J:144784,
J:144927
|
Retnlbtm1Gdw/Retnlbtm1Gdw
(involves: 129S/SvEv * C57BL/6)
|
decreased inflammatory response
|
J:114507
|
decreased susceptibility to induced colitis
|
J:114507
|
Retnlbtm1Mer/Retnlbtm1Mer
(involves: 129S1/Sv * C57BL/6)
|
decreased susceptibility to induced colitis
|
J:141524
|
Rhohtm1Hasu/Rhohtm1Hasu
(B6.Cg-Rhohtm1Hasu)
|
decreased susceptibility to type I hypersensitivity reaction
|
J:143491
|
Riox2tm1Mtsun/Riox2tm1Mtsun
(B6CrSlc.Cg-Riox2tm1Mtsun)
|
decreased inflammatory response
|
J:201871
|
Ripk3tm1Vmd/Ripk3tm1Vmd
(B6.129-Ripk3tm1Vmd)
|
decreased inflammatory response
|
J:179279
|
Rnf40tm1.1Sajo/Rnf40tm1.1Sajo Tg(Car1-cre)5Flt/0
(involves: 129S2/SvPas * C57BL/6J)
|
decreased susceptibility to induced colitis
|
J:311838
|
Rtl5em1Tmki/Rtl5em1Tmki Rtl6tm2.1Tmki/Rtl6tm2.1Tmki
(involves: C57BL/6NCrlj * C57BL/6NSlc * CBA/JNCrlj)
|
decreased susceptibility to endotoxin shock
|
J:329352
|
S1pr3tm1Jch/S1pr3tm1Jch
(involves: 129S1/Sv * 129X1/SvJ)
|
decreased susceptibility to endotoxin shock
|
J:133917
|
S100a9tm1Nck/S100a9tm1Nck
(B6.129P2-S100a9tm1Nck)
|
decreased susceptibility to endotoxin shock
|
J:125179
|
Sbsnem1Ham/Sbsnem1Ham
(C57BL/6N-Sbsnem1Ham)
|
decreased susceptibility to type IV hypersensitivity reaction
|
J:296400
|
Seletm2Alb/Seletm2Alb Selptm1Bay/Selptm1Bay
(involves: 129S7/SvEvBrd * C57BL/6)
|
decreased acute inflammation
|
J:112286
|
Selptm1Bay/Selptm1Bay
(B6.129S7-Selptm1Bay)
|
decreased susceptibility to type IV hypersensitivity reaction
|
J:121083
|
Sema4atm1Kik/Sema4atm1Kik
(either: B6.Cg-Sema4atm1Kik or C.Cg-Sema4atm1Kik)
|
decreased susceptibility to type IV hypersensitivity reaction
|
J:97027
|
Serpinb3atm1Gsil/Serpinb3atm1Gsil
(C.129-Serpinb3atm1Gsil)
|
decreased susceptibility to type I hypersensitivity reaction
|
J:189949
|
Serpine1tm1.1Vlp/Serpine1tm1.1Vlp
(involves: 129 * C57BL/6)
|
decreased susceptibility to endotoxin shock
|
J:229191
|
Serpine1tm1Mlg/Serpine1tm1Mlg
(involves: 129S2/SvPas)
|
decreased susceptibility to endotoxin shock
|
J:229191
|
Sh3yl1tm1Syb/Sh3yl1tm1Syb
(involves: C57BL/6N)
|
decreased susceptibility to endotoxin shock
|
J:298830
|
Slc3a2tm1.1Merl/Slc3a2+ Tg(Vil1-cre)997Gum/0
(B6.Cg-Slc3a2tm1.1Merl Tg(Vil1-cre)997Gum)
|
decreased susceptibility to induced colitis
|
J:173946
|
Slc15a4tm1Tkyo/Slc15a4tm1Tkyo
(involves: C57BL/6)
|
decreased susceptibility to induced colitis
|
J:270965
|
Slc37a4tm1Jyc/Slc37a4tm1Jyc
(involves: 129S4/SvJae * C57BL/6)
|
decreased inflammatory response
|
J:86005
|
Socs3tm1Ayos/Socs3tm1Ayos Lyz2tm1(cre)Ifo/Lyz2+
(involves: 129 * C57BL/6)
|
decreased susceptibility to endotoxin shock
|
J:92040
|
Sod3tm1Svp/Sod3tm1Svp
(involves: 129S6/SvEvTac * C57BL/6NTac)
|
decreased susceptibility to endotoxin shock
|
J:285340
|
Sphk1tm1Rlp/Sphk1tm1Rlp
(involves: 129S6/SvEvTac)
|
decreased susceptibility to endotoxin shock
|
J:133917
|
Spp1tm1Rit/Spp1tm1Rit
(involves: 129S7/SvEvBrd * C57BL/6)
|
decreased susceptibility to type IV hypersensitivity reaction
|
J:60284
|
Spp1tm1Rit/Spp1tm1Rit
(B6.129S7-Spp1tm1Rit)
|
decreased acute inflammation
|
J:93915
|
Stat1tm1Dlv/Stat1tm1Dlv
(involves: 129S/SvEv)
|
decreased susceptibility to endotoxin shock
|
J:130622
|
Stat1tm1Tdec/Stat1tm1Tdec
(involves: 129P2/OlaHsd * BALB/c)
|
decreased susceptibility to endotoxin shock
|
J:130622
|
Stat1tm2.1Uvin/Stat1tm2.1Uvin
(B6.129P2-Stat1tm2.1Uvin)
|
decreased susceptibility to endotoxin shock
|
J:209388
|
Stat3tm2Aki/Stat3tm2Aki Tlr4tm1Aki/Tlr4tm1Aki Lyz2tm1(cre)Ifo/Lyz2+
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased susceptibility to endotoxin shock
|
J:83280
|
Stim1tm1.1Kuro/Stim1+
(C57BL/6-Stim1tm1.1Kuro)
|
decreased susceptibility to type I hypersensitivity reaction
|
J:130477
|
Stx2tm1Dcru/Stx2tm1Dcru
(involves: 129X1/SvJ * C57BL/6J)
|
decreased susceptibility to induced colitis
|
J:110376
|
Stxbp2tm1Bdic/Stxbp2+
(involves: 129S * C57BL/6)
|
decreased susceptibility to type I hypersensitivity reaction
|
J:188931
|
Suv39h1tm1Jnw/Suv39h1tm1Jnw
(involves: 129)
|
decreased susceptibility to type I hypersensitivity reaction
|
J:186702
|
SykM2Btlr/Syk+
(C57BL/6J-SykM2Btlr)
|
decreased inflammatory response
|
J:231803
|
SykM2Btlr/SykM2Btlr
(C57BL/6J-SykM2Btlr)
|
decreased inflammatory response
|
J:231803
|
Tacr1tm1Sph/Tacr1tm1Sph
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased inflammatory response
|
J:46629
|
Tbxas1tm1Swl/Tbxas1tm1Swl
(involves: 129P2/OlaHsd * BALB/c * C57BL/6J)
|
decreased inflammatory response
|
J:90922
|
Terf2ipGt(XD108)Byg/Terf2ip+
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased susceptibility to endotoxin shock
|
J:163158
|
Tg(CAG-PGDS)1Groy/0
(involves: FVB/N)
|
decreased inflammatory response
|
J:107651
|
Tg(CD2-Ifngr2)1Pbro/?
(B6.Cg-Tg(CD2-Ifngr2)1Pbro)
|
decreased susceptibility to type IV hypersensitivity reaction
|
J:134448
|
Tg(CD2-S1PR1)1Ejg/?
(involves: C57BL/6 * DBA/2)
|
decreased susceptibility to type IV hypersensitivity reaction
|
J:96558
|
Tg(DO11.10)10Dlo/0 Crlf2tm1Wjl/Crlf2tm1Wjl
(involves: 129 * BALB/c * C3H * C57BL/6)
|
decreased inflammatory response
|
J:107431
|
Tg(Fabp1-cre)1Jig/0 Vhltm1Jae/Vhltm1Jae
(involves: 129S4/SvJae * BALB/c * FVB/N)
|
decreased susceptibility to induced colitis
|
J:93476
|
Tg(Il1rn)1Dih/0
(involves: C57BL/6 * CBA)
|
decreased inflammatory response
|
J:88605
|
decreased susceptibility to endotoxin shock
|
J:36387
|
Tg(Il1rn)1Dih/Tg(Il1rn)1Dih
(involves: C57BL/6 * CBA)
|
decreased susceptibility to endotoxin shock
|
J:36387
|
Tg(LCK-NFKBIA)5Dwb/?
(involves: BALB/c * C57BL/6 * DBA/2)
|
decreased susceptibility to type I hypersensitivity reaction
|
J:145531
|
decreased susceptibility to type IV hypersensitivity reaction
|
J:145531
|
Tg(Lck-VIPR2)1Ejg/0
(C57BL/6-Tg(Lck-VIPR2)1Ejg)
|
decreased susceptibility to type IV hypersensitivity reaction
|
J:127974
|
Tg(LYZ-rtTA2S*M2,tetO-ELAVL1)632Dkon/0
(B6.Cg-Tg(LYZ-rtTA2S*M2,tetO-ELAVL1)632Dkon)
|
decreased susceptibility to induced colitis
|
J:184388
|
Tg(Mcpt8-cre)1Voeh/0
(involves: C57BL/6)
|
decreased inflammatory response
|
J:164432
|
Tg(Msr1-MMP9)#Apar/0
(B6.Cg-Tg(Msr1-MMP9)#Apar)
|
decreased inflammatory response
|
J:129959
|
Tg(Mx1-cre)1Cgn/0 Znrf1tm1Lchs/Znrf1tm1Lchs
(involves: C57BL/6)
|
decreased susceptibility to endotoxin shock
|
J:250572
|
Tg(Myh6-Grem2)1Akh/0
(involves: C57BL/6)
|
decreased inflammatory response
|
J:250034
|
Tg(Tek-Tnf*)5382Mcla/0
(B6.Cg-Tg(Tek-Tnf*)5382Mcla)
|
decreased inflammatory response
|
J:71622
|
Tgm2tm1Gml/Tgm2tm1Gml
(involves: C57BL/6)
|
decreased susceptibility to endotoxin shock
|
J:131975
|
Ticam1Lps2/Ticam1Lps2
(involves: C57BL/6)
|
decreased susceptibility to endotoxin shock
|
J:84896
|
Ticam1Lps2/Ticam1Lps2
(C57BL/6J-Ticam1Lps2)
|
decreased susceptibility to induced colitis
|
J:167340
|
Ticam1tm1Aki/Ticam1tm1Aki
(involves: 129P2/OlaHsd)
|
decreased susceptibility to endotoxin shock
|
J:84679
|
Ticam1tm1Aki/Ticam1tm1Aki
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased susceptibility to type I hypersensitivity reaction
|
J:161445
|
Tlr2tm1Aki/Tlr2tm1Aki
(involves: 129P2/OlaHsd)
|
decreased inflammatory response
|
J:146111
|
Tlr3tm1Flv/Tlr3tm1Flv
(involves: 129S1/Sv * C57BL/6)
|
decreased inflammatory response
|
J:72167
|
Tlr4lps-n/Tlr4lps-n
(C3H/HeN)
|
decreased acute inflammation
|
J:37271
|
Tlr4tm1.1Djh/Tlr4tm1.1Djh
(involves: FVB/N)
|
decreased susceptibility to endotoxin shock
|
J:192520
|
Tlr4tm1Aki/Tlr4tm1Aki
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased susceptibility to endotoxin shock
|
J:76115
|
Tlr9tm1Aki/Tlr9tm1Aki
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased inflammatory response
|
J:66049
|
Tnftm1.1Sned/Tnftm1.1Sned Lyz2tm1(cre)Ifo/Lyz2+
(involves: 129 * 129P2/OlaHsd * C57BL/6)
|
decreased susceptibility to endotoxin shock
|
J:95684
|
Tnftm1.1Sned/Tnftm1.1Sned Tg(Cd4-cre)1Cwi/0
(involves: 129 * C57BL/6 * DBA/2)
|
decreased susceptibility to endotoxin shock
|
J:95684
|
Tnftm1Gkl/Tnftm1Gkl
(involves: 129S/SvEv * C57BL/6)
|
decreased inflammatory response
|
J:56068
|
decreased susceptibility to type IV hypersensitivity reaction
|
J:47673
|
Tnftm1Gkl/Tnftm1Gkl
(involves: 129S/SvEv)
|
decreased susceptibility to endotoxin shock
|
J:95684
|
Tnftm1Jods/Tnftm1Jods
(involves: C57BL/6)
|
decreased susceptibility to endotoxin shock
|
J:98591
|
Tnftm1Ljo/Tnftm1Ljo
(involves: 129S1/Sv)
|
decreased susceptibility to endotoxin shock
|
J:95684,
J:41992
|
Tnftm1Sek/Tnftm1Sek
(B6.Cg-Tnftm1Sek)
|
decreased susceptibility to endotoxin shock
|
J:44841
|
Tnftm2Gkl/Tnf+
(involves: 129S/SvEv * C57BL/6)
|
decreased inflammatory response
|
J:204922
|
Tnftm2Jods/Tnftm2Jods
(C57BL/6-Tnftm2Jods)
|
decreased susceptibility to endotoxin shock
|
J:98591
|
Tnftm3Gkl/Tnftm3Gkl
(involves: 129S/SvEv * C57BL/6)
|
decreased susceptibility to endotoxin shock
|
J:114740
|
Tnfaip3tm1.1Gvl/Tnfaip3tm1.1Gvl Tnfrsf1atm1Mak/Tnfrsf1atm1Mak Tg(Vil1-cre)997Gum/0
(involves: 129S2/SvPas * C57BL/6 * SJL)
|
decreased susceptibility to induced colitis
|
J:163410
|
Tnfaip6tm1Cful/Tnfaip6tm1Cful
(involves: 129S6/SvEvTac * BALB/c)
|
decreased inflammatory response
|
J:193758
|
Tnfrsf1atm1Imx/Tnfrsf1atm1Imx
(C57BL/6-Tnfrsf1atm1Imx)
|
decreased inflammatory response
|
J:45147
|
decreased susceptibility to endotoxin shock
|
J:45147
|
Tnfrsf1atm1Imx/Tnfrsf1atm1Imx
(C57BL/6-Tnfrsf1atm1Imx/J)
|
decreased susceptibility to endotoxin shock
|
J:160543
|
Tnfrsf1atm1Imx/Tnfrsf1atm1Imx Tnfrsf1btm1Imx/Tnfrsf1btm1Imx
(involves: 129S7/SvEvBrd * C57BL/6)
|
decreased inflammatory response
|
J:45147
|
decreased susceptibility to endotoxin shock
|
J:45147
|
Tnfrsf1atm1Rsie/Tnfrsf1atm1Rsie
(B6.Cg-Tnfrsf1atm1Rsie)
|
decreased susceptibility to endotoxin shock
|
J:160543
|
Tnfrsf1atm2.1Rsie/Tnfrsf1atm2.1Rsie
(B6.Cg-Tnfrsf1atm2.1Rsie)
|
decreased susceptibility to endotoxin shock
|
J:160543
|
Tnfrsf4tm1Nik/Tnfrsf4tm1Nik
(involves: 129S4/SvJae * C57BL/6)
|
decreased susceptibility to type I hypersensitivity reaction
|
J:68588
|
Tnfrsf11atm1.1Pngr/Tnfrsf11atm1.2Pngr Tg(Gfap-cre)2Brn/0
(involves: 129 * C57BL/6 * C57BL/6NTac * FVB/N)
|
decreased susceptibility to endotoxin shock
|
J:155398
|
Tnfrsf11atm1.1Pngr/Tnfrsf11atm1.2Pngr Tg(Nes-cre)1Kln/0
(involves: 129 * C57BL/6 * C57BL/6NTac * SJL)
|
decreased susceptibility to endotoxin shock
|
J:155398
|
Tnfrsf14tm1Csj/Tnfrsf14tm1Csj
(B6.Cg-Tnfrsf14tm1Csj)
|
decreased susceptibility to induced colitis
|
J:169369
|
Tnfsf4tm1Shr/Tnfsf4tm1Shr
(involves: 129S4/SvJae)
|
decreased susceptibility to type IV hypersensitivity reaction
|
J:59203
|
Tnfsf4tm1Sug/Tnfsf4tm1Sug
(B6.129S4-Tnfsf4tm1Sug)
|
decreased susceptibility to type IV hypersensitivity reaction
|
J:80214
|
Tnfsf14tm1Lpc/Tnfsf14tm1Lpc
(involves: 129X1/SvJ * C57BL/6)
|
decreased inflammatory response
|
J:107803
|
Tpsg1tm1.2Rls/Tpsg1tm1.2Rls
(involves: C57BL/6 * C57BL/6NTac)
|
decreased susceptibility to colitis induced morbidity/mortality
|
J:243813
|
Traddtm1.1Mak/Tradd+
(either: (involves: 129P2/OlaHsd * C57BL/6) or (involves: 129P2/OlaHsd * FVB/N))
|
decreased acute inflammation
|
J:138824
|
Traddtm1.1Mak/Traddtm1.1Mak
(either: (involves: 129P2/OlaHsd * C57BL/6) or (involves: 129P2/OlaHsd * FVB/N))
|
decreased acute inflammation
|
J:138824
|
decreased inflammatory response
|
J:138824
|
Traf3ip2tm1Sbn/Traf3ip2tm1Sbn
(involves: 129 * C57BL/6)
|
decreased inflammatory response
|
J:191090
|
Traj18tm1.1Kro/Traj18tm1.1Kro
(involves: C57BL/6NTac)
|
decreased inflammatory response
|
J:232957
|
Trap1Gt(E150H04)Wrst/Trap1Gt(E150H04)Wrst
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased inflammatory response
|
J:226880
|
Trim31em1Cya/Trim31em1Cya
(involves: C57BL/6)
|
decreased susceptibility to induced colitis
|
J:243237
|
Trip10tm1.1Geha/Trip10tm1.1Geha
(B6.129S1-Trip10tm1.1Geha)
|
decreased susceptibility to type IV hypersensitivity reaction
|
J:164363
|
Trpm2tm1Yamo/Trpm2tm1Yamo
(involves: 129S4/SvJae * C57BL/6J)
|
decreased inflammatory response
|
J:137676
|
Trpv1tm1Jul/Trpv1tm1Jul
(involves: 129X1/SvJ * C57BL/6)
|
decreased susceptibility to endotoxin shock
|
J:104828
|
Tslptm1(KOMP)Vlcg/Tslptm1(KOMP)Vlcg
(involves: C57BL/6 * C57BL/6NTac)
|
decreased acute inflammation
|
J:187770
|
Tyrobptm1.1Viv/Tyrobptm1.1Viv
(involves: 129P2/OlaHsd * BALB/cJ * C57BL/6)
|
decreased susceptibility to type IV hypersensitivity reaction
|
J:64764
|
Ube2nGt(OST374154)Lex/Ube2n+
(involves: 129S5/SvEvBrd * C57BL/6)
|
decreased susceptibility to endotoxin shock
|
J:120846
|
Vegfatm2Gne/Vegfatm2Gne Lyz2tm1(cre)Ifo/Lyz2+
(involves: 129/Sv * 129P2/OlaHsd)
|
decreased inflammatory response
|
J:107682
|
Vipr2tm1Ajh/Vipr2tm1Ajh
(B6.129P2-Vipr2tm1Ajh)
|
decreased susceptibility to type I hypersensitivity reaction
|
J:72933
|
Vsig4tm1Gne/Vsig4tm1Gne
(C57BL/6-Vsig4tm1Gne)
|
decreased susceptibility to induced colitis
|
J:281762
|
Zdhhc11tm1.1(KOMP)Vlcg/Zdhhc11tm1.1(KOMP)Vlcg
(involves: C57BL/6NTac)
|
decreased susceptibility to endotoxin shock
|
J:310891
|
Zfp36tm2.1Pjb/Zfp36tm2.1Pjb
(involves: C57BL/6)
|
decreased inflammatory response
|
J:229078
|